DR. Jana Marie Reynolds, M.D. is a medical oncology internal medicine in Dallas, TX with 16 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Jana Marie Reynolds, M.D. NPI is 1164656435. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
Education
Medical School: TEXAS TECH UNIVERSITY HEALTH SCIENCE CENTER SCHOOL OF MEDICINE
Graduation Year:2008
The provider's business location address is:
3410 WORTH ST STE 300
DALLAS, TX
ZIP 75246-012
Phone: (214) 370-1500
Fax: (214) 370-1512
The NPI 1164656435 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85025)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Injection of different drug or substance into a vein for therapy, diagnosis, or prevention (HCPCS:96375)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Infusion of chemotherapy into a vein up to 1 hour (HCPCS:96413)
- Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour (HCPCS:96367)
The enumeration date for this NPI number is 5/14/2009 and was last updated on 5/3/2017.